Related Experiment Video

Updated: Jun 21, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Catheter ablation for atrial fibrillation: a promising therapy for congestive heart failure

Dimpi Patel1, Andrea Natale, Luigi Di Biase

  • 1Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, TX 78705, USA. dimpi.patel.afib@gmail.com

Expert Review of Cardiovascular Therapy
|July 11, 2009
PubMed

Insights

Pulmonary vein antrum ablation is more effective than atrioventricular junction ablation for treating atrial fibrillation (AF) in patients with congestive heart failure (CHF). Curing AF significantly improves heart function and quality of life compared to AV junction ablation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Atrial fibrillation (AF) and congestive heart failure (CHF) are prevalent cardiovascular conditions.
  • Catheter ablation for AF is increasingly utilized in patients with comorbid CHF.
  • Drug-refractory AF in CHF patients presents significant management challenges.

Purpose of the Study:

  • To compare the efficacy of pulmonary vein antrum ablation versus atrioventricular junction ablation (AVJA) in patients with CHF.
  • To evaluate the impact of AF ablation strategies on cardiac function and quality of life in CHF patients.

Main Methods:

  • Review of ablation strategies for AF in patients with CHF.
  • Comparison of pulmonary vein antrum ablation and AVJA outcomes.
  • Assessment of morphological and functional improvements post-ablation.

Main Results:

  • Atrioventricular junction ablation (AVJA) with a biventricular device improved exercise capacity and quality of life in drug-refractory CHF patients.
  • Pulmonary vein antrum ablation demonstrated superiority over AVJA in a head-to-head comparison.
  • Achieving a cure for AF in CHF patients led to more substantial improvements than AVJA.

Conclusions:

  • Pulmonary vein antrum ablation is a superior strategy to AVJA for managing AF in patients with CHF.
  • Curing AF offers greater benefits for cardiac structure and function in CHF patients compared to AVJA.
  • These findings support optimizing AF management to improve outcomes in patients with coexisting CHF.

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...